KR

Kiritkumar Rambhai Patel

Active Director Director DIN 00380319
DIN 00380319 First appointment Jan 2010 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2010
Shareholding value •••• Premium profile

About Kiritkumar Rambhai Patel

Data last updated:

Kiritkumar Rambhai Patel is a Director at R K Synthesis Limited (since 2024), Director at Universal Medicap Limited (since 2010) and Director at Corel Pharma Chem (India) Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Manufacturing and Machinery and Equipment. The 3 current companies with reported revenue have a combined latest revenue of ₹248 Cr; the largest is R K Synthesis Limited at ₹156 Cr (FY 2025). Earlier, Kiritkumar Rambhai Patel was an Additional Director at Shilp Gravures Limited (2018–2019) and Director at C D Commodities Broking Limited (2015–2025).

DIN 00380319
Primary Designation Director
Industry Chemicals and Materials
First Appointment 28 Jan 2010
Oldest Company Age 34 yrs
Largest company R K Synthesis Limited · ₹156 Cr (FY 2025)
Combined revenue ₹248 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R K Synthesis Limited U24100GJ2015PLC083906
Director18 Dec 20242015₹156 Cr (FY 2025)Active
Universal Medicap Limited U24230GJ1992PLC018009
Director28 Jan 20101992₹91.31 Cr (FY 2025)Active
Director09 Oct 20202020₹1.01 Cr (FY 2025)Active
Corel Pharma Chem Private Limited U24233GJ2015PTC082980
Director23 Apr 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shilp Gravures Limited L27100GJ1993PLC020552
Additional Director04 Aug 20181993₹94.69 Cr (FY 2025)Active
C D Commodities Broking Limited U67120GJ2003PLC042067
Director14 Feb 20152003₹12.37 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
R K Synthesis Limited
Universal Medicap Limited
Corel Pharma Chem Private Limited
Corel Pharma Chem (India) Private Limited
Premium access

Shareholding and investment profile for Kiritkumar Rambhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiritkumar Rambhai Patel

Kiritkumar Rambhai Patel currently holds 4 directorships: R K Synthesis Limited (Director, since 18 Dec 2024, revenue ₹156 Cr (FY 2025)); Universal Medicap Limited (Director, since 28 Jan 2010, revenue ₹91.31 Cr (FY 2025)); Corel Pharma Chem (India) Private Limited (Director, since 09 Oct 2020, revenue ₹1.01 Cr (FY 2025)); Corel Pharma Chem Private Limited (Director, since 23 Apr 2015).

Kiritkumar Rambhai Patel was first appointed on 28 Jan 2010 as Director at Universal Medicap Limited. The most recent appointment on record is 18 Dec 2024 at R K Synthesis Limited.

The 3 current companies of Kiritkumar Rambhai Patel that report revenue have a combined latest revenue of ₹248 Cr: R K Synthesis Limited ₹156 Cr (FY 2025); Universal Medicap Limited ₹91.31 Cr (FY 2025); Corel Pharma Chem (India) Private Limited ₹1.01 Cr (FY 2025).

Kiritkumar Rambhai Patel held 2 earlier board appointments: Shilp Gravures Limited (Additional Director, 04 Aug 2018 to 26 Aug 2019); C D Commodities Broking Limited (Director, 14 Feb 2015 to 25 Mar 2025).

The current boards of Kiritkumar Rambhai Patel's companies include Joitarambhai Gandalal Patel (R K Synthesis Limited), Karshanbhai Gandalal Patel (R K Synthesis Limited), Lalit Jain (R K Synthesis Limited), Nihar Karsanbhai Patel (R K Synthesis Limited), Prashant Karsanbhai Patel (R K Synthesis Limited), Ashwinbhai Maganbhai Patel (Universal Medicap Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available